{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:02:52Z","timestamp":1779746572523,"version":"3.53.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OV3-170644"],"award-info":[{"award-number":["OV3-170644"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013212","name":"Centre in Green Chemistry and Catalysis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","award":["RS-265155"],"award-info":[{"award-number":["RS-265155"]}],"id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118698","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:21:10Z","timestamp":1771374070000},"page":"118698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integration of computational and experimental techniques for the discovery of PLpro covalent inhibitors. When large virtual screening and rational design meet"],"prefix":"10.1016","volume":"308","author":[{"given":"Ho Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Pinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Broqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Boulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s M.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaouba","family":"Souaibou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Huck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Huot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vlaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Pottel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hennecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jevgenijs","family":"Tjutrins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin E.","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Labarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Plescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Burai-Patrascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Laplante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chatel-Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K.","family":"Mittermaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6933-2079","authenticated-orcid":false,"given":"Nicolas","family":"Moitessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejmech.2026.118698_bib1","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1128\/JVI.03273-12","article-title":"A case for the ancient origin of coronaviruses","volume":"87","author":"Wertheim","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.118698_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"3280","key":"10.1016\/j.ejmech.2026.118698_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0262-4079(20)30862-9","article-title":"An uncommon cold","volume":"246","author":"King","year":"2020","journal-title":"New Sci."},{"key":"10.1016\/j.ejmech.2026.118698_bib4","article-title":"Coronavirus disease (COVID-19) dashboard","year":"2025","journal-title":"World Health Organization"},{"issue":"10242","key":"10.1016\/j.ejmech.2026.118698_bib5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118698_bib6","article-title":"Drug treatments for covid-19: living systematic review and network meta-analysis","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118698_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jama.2020.16337","article-title":"Efficacy of remdesivir in COVID-19","volume":"324","author":"McCreary","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejmech.2026.118698_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118698_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118698_bib11","article-title":"Merck and Ridgeback's Molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world","year":"2021","journal-title":"Merck & Co., Inc."},{"key":"10.1016\/j.ejmech.2026.118698_bib12","article-title":"FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults","year":"2021","journal-title":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.ejmech.2026.118698_bib13","article-title":"Discovery of a novel inhibitor of coronavirus 3CL protease for the potential treatment of COVID-19","author":"Boras","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2026.118698_bib14","series-title":"Study of PF-07321332 in Healthy Participants","year":"2021"},{"issue":"6575","key":"10.1016\/j.ejmech.2026.118698_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118698_bib17","article-title":"Nirmatrelvir resistance in SARS-CoV-2 Omicron BA1 and WA1 replicons and escape strategies","volume":"2022","author":"Lan","year":"2023","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.ejmech.2026.118698_bib18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","article-title":"Chemistry and biology of SARS-CoV-2","volume":"6","author":"D\u00f6mling","year":"2020","journal-title":"Chem"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118698_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118698_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2014 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118698_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsptsci.0c00093","article-title":"Can papain-like protease inhibitors halt SARS-CoV-2 replication?","volume":"3","author":"Maiti","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"7835","key":"10.1016\/j.ejmech.2026.118698_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.ejmech.2026.118698_bib24","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.02220-08","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling","volume":"83","author":"Frieman","year":"2009","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118698_bib25","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","article-title":"Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19","volume":"65","author":"Unoh","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118698_bib26","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","article-title":"Progress and challenges in targeting the SARS-CoV-2 papain-like protease","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"issue":"42","key":"10.1016\/j.ejmech.2026.118698_bib27","doi-asserted-by":"crossref","first-page":"eabd4596","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib28","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/s41598-021-83229-6","article-title":"Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2","volume":"11","author":"Weglarz-Tomczak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118698_bib29","article-title":"Structural basis for the inhibition of the papain-like protease of SARS-CoV-2 by small molecules","author":"Fu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2026.118698_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.876212","article-title":"Inhibitors of SARS-CoV-2 PLpro","volume":"10","author":"Calleja","year":"2022","journal-title":"Front. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118698_bib31","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.tips.2022.08.008","article-title":"Targeting SARS-CoV-2 papain-like protease in the postvaccine era","volume":"43","author":"Ton","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118698_bib32","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9965","article-title":"Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs","volume":"8","author":"Kouznetsova","year":"2020","journal-title":"PeerJ"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118698_bib33","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bmc.2019.03.050","article-title":"Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling","volume":"27","author":"Lee","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118698_bib34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","article-title":"Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease","volume":"6","author":"Freitas","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"42","key":"10.1016\/j.ejmech.2026.118698_bib35","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","article-title":"Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2","volume":"14","author":"Sanders","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118698_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103213","article-title":"6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro","volume":"24","author":"Swaim","year":"2021","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118698_bib39","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","article-title":"Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity","volume":"65","author":"Shen","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54462-0","article-title":"Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118698_bib41","doi-asserted-by":"crossref","first-page":"eado4288","DOI":"10.1126\/sciadv.ado4288","article-title":"Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model","volume":"10","author":"Garnsey","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib42","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/s41467-025-57905-4","article-title":"A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID","volume":"16","author":"Bader","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118698_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/ar50120a002","article-title":"Mechanisms of oxidative addition of organic halides to Group 8 transition-metal complexes","volume":"10","author":"Stille","year":"1977","journal-title":"Acc. Chem. Res."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118698_bib45","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/acs.jmedchem.5b02008","article-title":"Docking screens for novel ligands conferring new biology","volume":"59","author":"Irwin","year":"2016","journal-title":"J. Med. Chem."},{"issue":"7743","key":"10.1016\/j.ejmech.2026.118698_bib46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.ejmech.2026.118698_bib47","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1039\/D1SC05579H","article-title":"Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus deep docking of 40 billion small molecules","volume":"12","author":"Gentile","year":"2021","journal-title":"Chem. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118698_bib48","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/acs.jmedchem.0c02227","article-title":"Decision making in structure-based drug discovery: visual inspection of docking results","volume":"64","author":"Fischer","year":"2021","journal-title":"J. Med. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2026.118698_bib49","first-page":"S7","article-title":"Towards the development of universal, fast and highly accurate docking\/scoring methods: a long way to go","volume":"153","author":"Moitessier","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118698_bib50","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"Zinc 15 \u2013 ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118698_bib51","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.accounts.6b00185","article-title":"Medicinal chemistry projects requiring imaginative structure-based drug design methods","volume":"49","author":"Moitessier","year":"2016","journal-title":"Acc. Chem. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118698_bib52","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acs.jcim.1c00701","article-title":"Docking ligands into flexible and solvated macromolecules. 8. Forming new bonds\u2500challenges and opportunities","volume":"62","author":"Labarre","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/ci2004779","article-title":"Integrating medicinal chemistry, organic\/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with forecaster, a novel platform for drug discovery","volume":"52","author":"Therrien","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118698_bib54","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.chembiol.2019.09.012","article-title":"Recent advances in selective and irreversible covalent ligand development and validation","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118698_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70275","article-title":"Inhibitor-induced dimerization mediates lufotrelvir resistance in mutants of SARS-CoV-2 3C-like protease","volume":"34","author":"Wang","year":"2025","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.118698_bib57","series-title":"BIOVIA Discovery Studio Visualizer","author":"Biovia","year":"2020"},{"key":"10.1016\/j.ejmech.2026.118698_bib58","series-title":"Schr\u00f6dinger, LLC","author":"System","year":"2020"},{"issue":"6489","key":"10.1016\/j.ejmech.2026.118698_bib59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118698_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004113","article-title":"Structural basis for the Ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease","volume":"10","author":"Ratia","year":"2014","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118698_bib61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-2836(83)80284-8","article-title":"Studies on transformation of Escherichia coli with plasmids","volume":"166","author":"Hanahan","year":"1983","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1745-7254.2005.00010.x","article-title":"Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique","volume":"26","author":"Chen","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118698_bib63","first-page":"422","article-title":"Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, Delta, and omicron variants","volume":"3","author":"Banerjee","year":"2022","journal-title":"Med (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2026.118698_bib64","doi-asserted-by":"crossref","first-page":"RP94347","DOI":"10.7554\/eLife.94347.3","article-title":"Zika virus remodels and hijacks IGF2BP2 ribonucleoprotein complex to promote viral replication organelle biogenesis","volume":"13","author":"Mazeaud","year":"2024","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118698_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111599","article-title":"Dengue virus and zika virus alter endoplasmic reticulum-mitochondria contact sites to regulate respiration and apoptosis","volume":"28","author":"Freppel","year":"2025","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118698_bib66","article-title":"N-Phenylpyridine-3-carboxamide and 6-acetyl-1H-indazole inhibit the RNA replication step of the dengue virus life cycle","volume":"67","author":"Sow A\u00efssatou","year":"2023","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T21:14:12Z","timestamp":1779743652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":64,"alternative-id":["S0223523426001431"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118698","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of computational and experimental techniques for the discovery of PLpro covalent inhibitors. When large virtual screening and rational design meet","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118698"}}